Publish Time: 2021-04-26 Origin: Site
Rhodiola rosea has been used in traditional medicinal herbs in China, Siberia and the Carpathian region of Ukraine. Rhodiola rosea does have a certain inhibitory effect on S180 cells, and within the range of non-toxic side doses, this effect increases with the increase in concentration. Continuous oral administration of Rhodiola rosea extract can reduce the carcinogenic damage to the small intestinal wall of mice by erythromycin and improve the body's anti-cancer ability.
Taking rhodiola extract has shown potential as an anti-cancer drug, and may be very effective when used in combination with several anti-cancer drugs. Transplanting mice with solidified Ehrich adenocarcinoma and metastatic Pulis lymphosarcoma in mice, supplemented with rhodiola extract inhibits the growth of all types of tumors, reduces metastasis to the liver and prolongs survival time. . Taking it can also directly inhibit the growth and metastasis of the transplanted Lewis lung malignant tumor.
When the rhodiola extract and the anti-tumor drug cyclophosphamide are used in combination to treat the same tumor model, the anti-tumor and anti-metastasis effects of the drug are effectively improved. The existence of free radicals is related to cell mutation, the direct cause of cancer. In addition, Soviet scientists found that oral administration of rhodiola inhibited 39% of experimental rats' tumor growth and reduced 50% of rats' metastasis. It can improve the urinary tissue and immunity of patients with bladder cancer. In experiments on various other cancers, including adenocarcinoma (glandular tissue cancer such as breast cancer) and lung malignancies. Rhodiola extracts all led to a significant increase in the survival rate.